Francis Burrows - 02 Jan 2026 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Scientific Officer
Signature
Teresa Bair, Attorney-in-fact for Francis Burrows
Issuer symbol
KURA
Transactions as of
02 Jan 2026
Net transactions value
$0
Form type
4
Filing time
06 Jan 2026, 16:30:08 UTC
Previous filing
19 Dec 2025
Next filing
27 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Burrows Francis Chief Scientific Officer C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO Teresa Bair, Attorney-in-fact for Francis Burrows 06 Jan 2026 0002051119

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +185,000 $0.000000 185,000 02 Jan 2026 Common Stock 185,000 $10.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in 48 equal monthly installments commencing on the grant date.